Xinermei (mazdutide) - Eli Lilly
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity (clinicaltrials.gov) - Sep 23, 2026 - P2 | N=141 | Active, not recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Recruiting ➔ Active, not recruiting 
Enrollment closed • Cardiovascular • Congestive Heart Failure • Genetic Disorders • Heart Failure • Obesity
http://clinicaltrials.gov/ct2/show/NCT06862908
 
Sep 23, 2026
 
Prev Next